Glucose regulation of CDK7, a putative thiol related gene, in experimental diabetic nephropathy

Biochemical and Biophysical Research Communications

Volumn 357, Issue 1, 2007, Pages 237-244

  Malik, Afshan N ^a   Rossios, Christos ^a   Al Kafaji, Ghada ^a   Shah, Akram ^a   Page, Rachel A ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

Diabetic nephropathy; Glucose regulation; Hyperglycemia; Mesangial cells; Oxidative stress; Thiol

Indexed keywords

AMINO ACID; CYCLIN DEPENDENT KINASE 7; CYSTEINYLPROLYLARGINYLCYSTEINE; GLUCOSE; GLUCOSE REGULATED PROTEIN; MESSENGER RNA; THIOREDOXIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CATALYSIS; CLONING; CONTROLLED STUDY; DIABETIC NEUROPATHY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GOTO KAKIZAKI RAT; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; KIDNEY CELL; LIVER; MESANGIUM CELL; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STEADY STATE; WISTAR RAT;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; GLUCOSE; HUMANS; KIDNEY; MOLECULAR SEQUENCE DATA; OXIDATIVE STRESS; RATS; RATS, WISTAR; SULFHYDRYL COMPOUNDS;

RATTUS; RATTUS NORVEGICUS;

EID: 34147172719     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.03.132     Document Type: Article

References (37)

1. Page R.A., Morris C.A., Williams J.D., von Ruhland C.J., and Malik A.N. Isolation of diabetes-associated kidney genes using differential display. Biochem. Biophys. Res. Commun. 232 (1997) 49-53
2. Schena F.P., and Gesualdo L. Pathogenetic mechanisms of diabetic nephropathy. J. Am. Soc. Nephrol. 16 (2005) 30-33
3. Ritz E., Rychlik I., Locatelli F., and Halimi S. End stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am. J. Kid Dis. 34 (1999) 795-808
4. Groop P., Forsblom C., and Thomas M.C. Mechanisms of disease: pathway-selective insulin resistance and micorvascular complications of diabetes. Nat. Clin. Pract. Endocrin. Metab. 1 (2005) 100-110
5. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
6. Brownlee M. The pathobiology of diabetic complications. Diabetes 54 (2005) 1615-1625
7. Mason R., and Wahab N.A. Extracellular matrix metabolism in diabetic nephropathy: frontiers in nephrology. J. Am. Soc. Nephrol. 14 (2003) 1358-1373
8. Wada J., Makino H., and Kanwar Y.S. Gene expression and identification of gene therapy targets in diabetic nephropathy. Kid. Int. 61 Symposium 1 (2002) S73-S78
9. Burns W.C., Twigg S.M., Forbes J.M., Pete J., Tikellis C., Thallas-Bonke V., Thomas M.C., Cooper M.E., and Kantharidis P. Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J. Am. Soc. Nephrol. 17 (2006) 2484-2494
10. Dolan V., Murphy M., Alarcon P., Brady H.R., and Hensey C. Gremlin-a putative pathogenic player in progressive renal disease. Expert Opin. Ther. Targets 7 (2003) 523-526
11. Feng Y., Wang Q., Wang Y., Yard B., and Lang F. SGK1-mediated fibronectin formation in diabetic nephropathy. Cell. Physiol. Biochem. 16 (2005) 237-244
12. Sun L., Pan X., Wada J., Haas C.C., Wuthrich R.P., Danesh F.R., Chugh S.S., and Kanwar Y.S. Isolation and functional analysis of mouse UbA52 gene and its relevance to diabetic nephropathy. J. Biol. Chem. 277 33 (2002) 29953-29962
13. Page R.A., and Malik A.N. Elevated levels of beta defensin-1 mRNA in diabetic kidneys of GK rats. Biochem. Biophys. Res. Commun. 310 (2003) 513-521
14. Malik A.N., and Al-Kafaji G. Glucose regulation of β-defensin-1 mRNA in human renal cells. Biochem. Biophys. Res. Commun. 353 (2007) 318-323
15. C.A. Morris, Molecular biology of diabetic nephropathy. PhD Thesis, Cardiff University, 1996.
16. Malik A.N., Zaidi Q., Morris C.A., and Williams J.D. Cloning of abundantly expressed candidate diabetes associated kidney genes. J. Am. Soc. Nephrol. 8 (1997) A2995
17. Goto Y., and Kakizaki M. The spontaneous diabetes rat: a model of non-insulin-dependent diabetes mellitus. Pro. Japan Acad. 57 (1981) 381-384
18. Cox N.J., Wapelhorst B., Morrison V.A., Johnson L., Pinchuk L., Spielman R.S., Todd J.A., and Concannon P. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am. J. Hum. Genet. 69 (2001) 820-830
19. Ewens K.G., Johnson L.N., Wapelhorst B., O'Brien K., Gutin S., Morrison V.A., Street C., Gregory S.G., Spielman R.S., and Concannon P. Linkage and association with type 1 diabetes on chromosome 1q42. Diabetes 51 (2002) 3318-3325
20. Wiltshire A., Hattersley A.T., Hitman G.A., Walker M., Levy J.C., Sampson M., O'Rahilly S., Frayling T.M., Bell J.T., Lathrop M., Bennett A., Dhillon R., Fletcher C., Groves C.J., Jones E., Prestwich P., Simecek N., Rao P.V.S., Wishart M., Foxon R., Howell S., Smedley D., Cardon L.R., Menzel M., and McCarthy M.I. Genomewide scan for loci predisposing to type 2 diabetes in a UK population [The Diabetes UK Warren 2 Repository]: analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am. J. Hum. Genet. 69 (2001) 553-569
21. Schulze P.C., Yoshioka J., Takahashi T., He Z., King G.L., and Lee R.T. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J. Biol. Chem. 279 (2004) 30369-30374
22. Sheetz M.J., and King G.L. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. J. Am. Med. Assoc. 288 (2002) 2579D-2588D
23. Reeves W.B., and Andreoli T.E. Transforming growth factor β contributes to progressive diabetic nephropathy. Proc. Natl. Acad. Sci. USA 97 (2000) 7667-7669
24. Brownlee M., Cerami A., and Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318 (1998) 1315-1321
25. Way K.J., Katai N., and King G.L. Protein kinase C and the development of diabetic vascular complications. Diabet. Med. 18 (2001) 945-959
26. Inoguchi T., Li P., Umeda F., Yu H.Y., Kakimoto M., Imamura M., Aoki T., Etoh T., Hashimoto T., Naruse M., Sano H., Utsumi H., and Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49 (2000) 1939-1945
27. Lee B.H., Ha H., and King G.L. Reactive oxygen species and diabetic nephropathy. J. Am. Soc. Nephrol. 14 (2003) S209-S210
28. Lee H.B., Yu M.-R., Yang Y., Jiang Z., and Ha H. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J. Am. Soc. Nephrol. 14 (2003) S241-S245
29. Nordberg J., and Arner E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31 (2001) 1287-1312
30. Hu T., RamachandraRao S.P., Siva S., Valancius C., Zhu Y., Mahadev K., Toh I., Goldstein B.J., Woolkalis M., and Sharma K. Reactive oxygen species production of NADPH oxidase mediates TFG-b induced cytoskeletal alterations in endothelial cells. Am. J. Physiol. Renal Physiol. 289 (2005) F816-F825
31. Anantharaman V., and Aravind L. MOSC domains: ancient, predicted sulfur-carrier domains, present in diverse metal-sulfur cluster biosynthesis proteins including molybdenum cofactor sulfurases. FEMS Microbiol. Lett. 207 (2002) 55-61
32. Rajagopalan K.V., and Johnson J.L. The pterin molybdenum cofactors. J. Biol. Chem. 25 (1992) 10199-10202
33. Liang M., and Pietrusz J.L. Thiol-related genes in diabetic complications: a novel protective role for endogenous thioredoxin 2. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 77-83
34. Ceriello A., Morocutti A., Mercuri F., Quagliaro L., Moro M., Damante G., and Viberti G.C. Defective intracellular antioxidant enzyme production in type1 diabetic patients with nephropathy. Diabetes 49 (2000) 2170-2177
35. Hodgkinson A.D., Bartlett T., Oates P.J., Millward B.A., and Demaine A.G. The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy. Diabetes 52 (2003) 846-851
36. Morrison J., Knoll K., Hessner M.J., and Liang M. Effect of high glucose on gene expression in mesangial cells: upregulation of the thiol pathway is an adaptational response. Physiol. Genomics. 17 (2004) 271-282
37. Nosadini R., and Tonolo G. Relationship between blood glucose control, pathogenesis and progression of diabetic nephropathy. J. Am. Soc. Nephrol. 15 (2004) S1-S5